Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

646 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT03329950

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
Locations
  • HonorHealth Research Insititute Scottsdale, Arizona, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View Trial Details
Completed

Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors

NCT03010982

Conditions
Advanced Solid Tumors, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +17 more
Locations
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom
  • Royal Liverpool and Broadgreen University Hospital Trust Liverpool, United Kingdom
View Trial Details
Completed

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

NCT04858568

Conditions
Burkitt Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +42 more
Locations
  • Bedfordshire Hospitals NHS Foundation Trust Bedford, Bedfordshire, United Kingdom
  • Portsmouth Hospitals University NHS Trust Portsmouth, Hampshire, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom
  • Wye Valley NHS Trust Hereford, Herefordshire, United Kingdom
View Trial Details
Completed

Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

NCT00075946

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
View all 483 locations
View Trial Details
Completed

A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)

NCT03833180

Conditions
Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +49 more
Locations
  • City of Hope ( Site 0010) Duarte, California, United States
  • University of California - San Diego ( Site 0003) La Jolla, California, United States
  • UCLA Hematology & Oncology ( Site 0007) Los Angeles, California, United States
  • University of Nebraska Medical Center ( Site 0006) Omaha, Nebraska, United States
View all 14 locations
View Trial Details

Related conditions